Company BGI Genomics Co., Ltd.

Equities

300676

CNE100003449

Biotechnology & Medical Research

Business description: BGI Genomics Co., Ltd.

Sales by Activity: BGI Genomics Co., Ltd.

Geographical breakdown of sales: BGI Genomics Co., Ltd.

Managers: BGI Genomics Co., Ltd.

Members of the board: BGI Genomics Co., Ltd.

Shareholders: BGI Genomics Co., Ltd.

Holdings: BGI Genomics Co., Ltd.

Company details: BGI Genomics Co., Ltd.

Bio Diagnostics & Testing

Sector

Income Statement and Estimates

End-of-day quote Shenzhen S.E. Other stock markets 2025-01-22			5-day change	1st Jan Change
38.14 ^CNY	-2.36%		-4.24%	-9.13%

Oct. 25	BGI Genomics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
Sep. 13	BGI Genomics Gets Registration for Expanded Use of Hereditary Deafness Gene Detection Kit	MT

BGI Genomics Co., Ltd. is a leading provider of genomic and proteomic sequencing services primarily to academic institutions, pharmaceutical companies and healthcare providers. The company also provides genomic solutions for biomarker research and development, screening for some of the trisomies present at birth (trisomy 21, trisomy 18 and trisomy 13) and solutions for neo-antigen identification for immuno-oncology research.

Fiscal Period: December	2019	2020	2021	2022	2023
Medical Labs & Research	2.8B	8.4B	6.77B	7.05B	4.35B

See all business segments

Fiscal Period: December	2019	2020	2021	2022	2023
Mainland China (Excluding Hong Kong, Macau and Taiwan)	2.34B	2.8B	2.88B	3.62B	3.46B
Asia (Including China, Hong Kong, Macau, and Taiwan) and Oceania	144M	3.78B	2.51B	2.79B	558M
Europe and Africa	193M	990M	939M	389M	217M
Americas	127M	833M	432M	245M	116M

See all geographic segments

Director	Title	Age	Since
Li Jian Zhao CEO	Chief Executive Officer	49	2021-06-15
Yu Jue Wang DFI	Director of Finance/CFO	47	2021-06-15
Li Ping Ao IRC	Investor Relations Contact	-	-
Qian Xu SEC	Corporate Secretary	41	2015-06-21

See BGI GENOMICS CO., LTD. governance

Manager	Title	Age	Since
Jian Wang CHM	Chairman	71	2015-06-21
Yu Jie Hu BRD	Director/Board Member	41	2015-06-21
Li Jian Zhao BRD	Director/Board Member	49	2021-06-15
Lan Du BRD	Director/Board Member	49	2021-08-12
Si Qi Liu CHM	Chairman	72	2021-06-15
Yu Jue Wang BRD	Director/Board Member	47	2024-06-17
Li Sheng Yu BRD	Director/Board Member	52	2023-07-19

Composition of the Board of Directors

Name	Equities	%	Valuation
Jian Wang 37.32 %	153,344,167	37.32 %	882 M ¥
Jun Wang 8.389 %	34,470,455	8.389 %	198 M ¥
Wanjia Asset Management Co., Ltd. 3.139 %	12,899,558	3.139 %	74 M ¥
Hwabao WP Fund Management Co., Ltd. 1.949 %	8,009,573	1.949 %	46 M ¥
Nanji E Commerce Co. Ltd. ESOP 2 0.9734 %	4,000,141	0.9734 %	23 M ¥

Name	Equities	%	Valuation
Jian Wang 63.66 %	1,903,350	63.66 %	11 M ¥

List of BGI GENOMICS CO., LTD. shareholders

Name	Equities	%	Valuation
BANGKOK GENOMICS INNOVATION 37.40%	224,400,000	37.40%	14,480,532 $

BGI Genomics Co., Ltd.

8/F, Block B, Huada Space Center 9 Yunhua Road

518083, Shenzhen

http://www.bgi.com

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
BGI GENOMICS CO., LTD.	-2.36%	-4.24%	-3.93%	-57.15%	2B
EXACT SCIENCES CORPORATION	+0.98%	+2.37%	-17.00%	-25.99%	10.14B
VERACYTE, INC.	-1.26%	+3.19%	+63.25%	+59.68%	3.34B
IOVANCE BIOTHERAPEUTICS, INC.	+1.87%	+1.35%	-25.87%	-57.09%	1.83B
CAREDX, INC	+2.16%	+2.16%	+136.39%	-37.38%	1.24B
ADAPTIVE BIOTECHNOLOGIES CORPORATION	+7.52%	+11.87%	+88.92%	-51.13%	1.18B
SEEGENE, INC.	+1.05%	-3.21%	-1.02%	-59.88%	775M
MARAVAI LIFESCIENCES HOLDINGS, INC.	+1.72%	+16.67%	-16.74%	-78.25%	755M
VIMTA LABS LIMITED	-0.67%	+4.10%	+96.96%	+125.80%	222M
CURIOX BIOSYSTEMS CO., LTD	-2.89%	-6.17%	+9.23%	-	218M
Average	+0.85%	+2.25%	+33.02%	-20.15%	2.17B
Weighted average by Cap.	+0.80%	+2.55%	+12.37%	-21.76%

See all sector performances

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Diagnostics & Testing

income-statement-evolution-chart BGI-GENOMICS-CO-LTD

More financial data